The optimal use of bexarotene in cutaneous T-cell lymphoma.
Gniadecki R, Assaf C, Bagot M, Dummer R, Duvic M, Knobler R, Ranki A, Schwandt P, Whittaker S.
Gniadecki R, et al.
Br J Dermatol. 2007 Sep;157(3):433-40. doi: 10.1111/j.1365-2133.2007.07975.x. Epub 2007 Jun 6.
Br J Dermatol. 2007.
PMID: 17553039
Review.